Immunovant (IMVT) Change in Account Payables (2019 - 2026)
Immunovant (IMVT) posted Change in Account Payables of -$1.3 million for Q1 2026, down 186.31% on a QoQ basis from $1.6 million in Q4 2025, and up 41.45% year-over-year from -$953696.2 in Q1 2025.
Immunovant (IMVT) Change in Account Payables (2019 - 2026) Analysis & Trends
Immunovant's Change in Account Payables history runs 8 years deep, the most recent figure standing at -$1.3 million for Q1 2026.
- Quarterly Change in Account Payables rose 41.45% year-over-year to -$1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$10.3 million (down 195.96% YoY) and the FY2026 annual result came in at -$10.3 million, down 195.96% from the prior year.
- Change in Account Payables was -$1.3 million for Q1 2026 at Immunovant, down from $1.6 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $25.0 million in Q2 2023 and bottomed at -$18.9 million in Q3 2023.
- A 5-year average of $1.2 million and a median of $1.6 million in 2025 frame the typical range for Change in Account Payables.
- Peak annual rise in Change in Account Payables reached 1727.02% in 2022, while the deepest fall reached 2690.37% in 2022.
- Immunovant's Change in Account Payables stood at $6.5 million in 2022, then plunged by 157.23% to -$3.7 million in 2023, then jumped by 92.98% to -$260000.0 in 2024, then jumped by 701.15% to $1.6 million in 2025, then tumbled by 186.31% to -$1.3 million in 2026.
- Business Quant data shows IMVT's Change in Account Payables at -$1.3 million in Q1 2026, $1.6 million in Q4 2025, and -$1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Immunovant | 7.18 Bn | 7.18 Bn | - | -1.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.35 Mn |
| Mar 31, 2026 | -1.35 Mn |
| Dec 31, 2025 | 1.56 Mn |
| Dec 31, 2025 | 1.56 Mn |
| Sep 30, 2025 | -1.07 Mn |
| Sep 30, 2025 | -1.07 Mn |
| Jun 30, 2025 | -9.40 Mn |
| Jun 30, 2025 | -9.40 Mn |
| Mar 31, 2025 | -2.30 Mn |
| Mar 31, 2025 | -2.30 Mn |
| Dec 31, 2024 | -260,000.00 |
| Dec 31, 2024 | -260,000.00 |
| Sep 30, 2024 | 9.37 Mn |
| Sep 30, 2024 | 9.37 Mn |
| Jun 30, 2024 | 3.88 Mn |
| Jun 30, 2024 | 3.88 Mn |
| Mar 31, 2024 | 3.39 Mn |
| Mar 31, 2024 | 3.39 Mn |
| Dec 31, 2023 | -3.70 Mn |
| Dec 31, 2023 | -3.70 Mn |